Patent details

EP2807151 Title: APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR

Basic Information

Publication number:
EP2807151
PCT Application Number:
PCT/US/2013/022997
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137036752
PCT Publication Number:
WO/2013/112741
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR
French Title of Invention:
INHIBITEUR DE LA KINASE RÉGULANT LES SIGNAUX DE L'APOPTOSE
German Title of Invention:
APOPTOSESIGNALREGULIERENDER KINASEHEMMER
SPC Number:

Dates

Filing date:
24/01/2013
Grant date:
18/11/2015
EP Publication Date:
18/11/2015
PCT Publication Date:
01/08/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/12/2014
EP B1 Publication Date:
18/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/01/2013
 
 

Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
14/12/2015
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
NOTTE Gregory
Address:
United States (US)

Priority

Priority Number:
201261591710
Priority Date:
27/01/2012
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 233/56;

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/01/2026
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56